| Investor Name | Lead Investor | Funding Round |
|---|---|---|
RTW Investments
|
Yes | Series C |
Takeda
|
Yes | Series B |
Eight Roads Ventures
|
Yes | Series Unknown |
|
|
- | Series C |
Brace Pharma
|
- | Series C |
Cormorant Asset Management
|
- | Series C |
CureDuchenne Ventures
|
- | Series C |
Eli Lilly
|
- | Series C |
|
|
- | Series C |
Partner Fund Management
|
- | Series C |
Perceptive Advisors
|
- | Series C |
Takeda Ventures
|
- | Series C |
|
|
- | Series B |
F-Prime Capital
|
- | Series B |
Moore Venture Partners
|
- | Series B |
Real Estate Equities
|
- | Series B |
Tavistock Life Sciences
|
- | Series B |